U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7596175961Imaging Studies and the Development of Multiple MyelomaWithdrawnNo Results AvailableMultiple Myeloma|Smoldering Multiple Myeloma|Monoclonal Gammopathy of Undetermined SignificanceDrug: Fluciclatidehttps://ClinicalTrials.gov/show/NCT01571726
7596275962Side Effects of Pulmonary Hypertension MedicationsRecruitingNo Results AvailablePulmonary Hypertensionhttps://ClinicalTrials.gov/show/NCT01571713
7596375963Investigation of Dysynchrony in Patients With Pulmonary HypertensionRecruitingNo Results AvailablePulmonary HypertensionProcedure: Catheterization Pacinghttps://ClinicalTrials.gov/show/NCT01571700
7596475964Pik Lenin High Altitude Research Expedition 2009CompletedNo Results AvailableOxidative Stress|Cell-derived MicroparticlesDietary Supplement: antioxidant supplements|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01571687
7596575965Validation of a Clinical Prediction Rule to Identify Patients With Shoulder Pain Likely to Benefit From Cervicothoracic Manipulation: A Randomized Clinical TrialNot yet recruitingNo Results AvailableShoulder PainProcedure: Manipulation + Exercise Group|Procedure: Exercise Grouphttps://ClinicalTrials.gov/show/NCT01571674
7596675966A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: GSK189075A|Other: Placebohttps://ClinicalTrials.gov/show/NCT01571661
7596775967A Phase 1 Study to Evaluate the Pharmacokinetics and Tolerability of Oral Azacitidine in Japanese Patients With Myelodysplastic SyndromesCompletedNo Results AvailableMyelodysplastic SyndromesDrug: Oral azacitidinehttps://ClinicalTrials.gov/show/NCT01571648
7596875968Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.Active, not recruitingNo Results AvailableBeta Thalassemia Major|Beta Thalassemia IntermediaDrug: Dose level 1a|Drug: Dose level 1b|Drug: Dose level 2|Drug: dose level 3|Drug: dose level 4|Drug: dose level 5https://ClinicalTrials.gov/show/NCT01571635
7596975969Whey Protein on Posprandial Glucose, Insulin GLP-1, GIP and DPP4 in Type 2 DiabetesCompletedNo Results AvailableType 2 Diabetes MellitusDietary Supplement: Whey before Breakfast|Dietary Supplement: Water before breakfasthttps://ClinicalTrials.gov/show/NCT01571622
7597075970Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic DisordersCompletedNo Results AvailableHyperlipidemia|Diabetes Mellitus|Metabolic Syndrome|Arterial Hypertension|ObesityOther: first phase insulin secretion (FPIR), Hyperinsulinemic euglycemic clamp (HEC), glucose tracer, and palmitate tracerhttps://ClinicalTrials.gov/show/NCT01571609
7597175971An Extension Study of KRN23 in Adults With X-Linked HypophosphatemiaCompletedNo Results AvailableX-linked HypophosphatemiaDrug: Biological KRN23https://ClinicalTrials.gov/show/NCT01571596
7597275972An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver TransplantationCompletedNo Results AvailableChronic Hepatitis C Virus (HCV) InfectionDrug: Telaprevir|Drug: Pegylated interferon alfa-2a|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT01571583
7597375973A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.CompletedNo Results AvailableHealthy VolunteersDrug: TMC435 150 mg capsule|Drug: TMC435 150 mg oral suspension (20 mg/mL)|Drug: TMC435 150 mg oral solution (10 mg/mL)|Drug: TMC435 150 mg capsule concept K|Drug: TMC435 150 mg capsule concept Lhttps://ClinicalTrials.gov/show/NCT01571570
7597475974A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)CompletedHas ResultsMacular Edema|Retinal Vein OcclusionDrug: dexamethasone 700 ug intravitreal implanthttps://ClinicalTrials.gov/show/NCT01571557
7597575975The Use of Thermal Suits as Preventing Hypothermia During SurgeryCompletedNo Results AvailableProstate CancerDevice: Thermal suit|Other: Conventional clothinghttps://ClinicalTrials.gov/show/NCT01571544
7597675976European Multicentre Study of Human Spinal Cord InjuryRecruitingNo Results AvailableSpinal Cord Injuryhttps://ClinicalTrials.gov/show/NCT01571531
7597775977Prevention of Neutropenia After Using G-CSF With TAC ChemotherapyNot yet recruitingNo Results AvailableNeutropeniaDrug: late leukostim|Drug: early leukostimhttps://ClinicalTrials.gov/show/NCT01571518
7597875978Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)Active, not recruitingNo Results AvailablePoliomyelitis|Tropical EnteropathyBiological: IPV vaccinationhttps://ClinicalTrials.gov/show/NCT01571505
7597975979Continuous L2 Paravertebral Block Versus Continuous Lumbar Plexus Block for Postoperative AnalgesiaActive, not recruitingNo Results AvailableTotal Hip ArthroplastyProcedure: L2 Paravertebral catheter nerve block|Procedure: Continuous Lumbar plexus nerve blockhttps://ClinicalTrials.gov/show/NCT01571492
7598075980The Feasibility and Safety of a Three-Port Laparoscopic Cholecystectomy Using a 2-mm Mini-InstrumentCompletedNo Results AvailableGallbladder DiseaseProcedure: 2- mini-instrumenthttps://ClinicalTrials.gov/show/NCT01571479
7598175981A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAARTCompletedNo Results AvailableHIV InfectionDrug: Vaccination|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01571466
7598275982Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian CountriesCompletedHas ResultsMajor Depressive DisorderDrug: Vortioxetine (Lu AA21004)|Drug: Venlafaxine extended releasehttps://ClinicalTrials.gov/show/NCT01571453
7598375983Soluble Corn Fiber and Calcium Utilization in AdolescentsCompletedNo Results AvailableOsteoporosisDietary Supplement: No soluble corn fiber|Dietary Supplement: 12 g soluble corn fiberhttps://ClinicalTrials.gov/show/NCT01571440
7598475984Conversations as a Means to Delay the Onset of Alzheimer's DiseaseCompletedNo Results AvailableCognitive ImpairmentBehavioral: Active social engagement group|Behavioral: Control grouphttps://ClinicalTrials.gov/show/NCT01571427
7598575985Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or RifampinCompletedNo Results AvailableTuberculosisDrug: PA-824|Drug: Efavirenz (EFV)|Drug: Lopinavir/Ritonavir (LPV/r)|Drug: Rifampin (RIF)https://ClinicalTrials.gov/show/NCT01571414
7598675986Trying Activity in Kidney Cancer Survivors (TRACKS) TrialCompletedNo Results AvailableSupervised Physical Activity Plus Exercise Counseling|Supervised Physical Activity Plus Behavioural CounselingBehavioral: Trying Activity for Kidney Cancer Survivors (TRACKS) Trialhttps://ClinicalTrials.gov/show/NCT01571401
7598775987A Study To Compare Pharmacokinetics Of Dacomitinib (PF-00299804) Between Healthy Subjects And Subjects With Mild And Moderate Hepatic ImpairmentCompletedNo Results AvailableHealthy|Otherwise Healthy Volunteers With Mild or Moderate Hepatic DysfunctionDrug: dacomitinib|Drug: dacomitinib|Drug: dacomitinibhttps://ClinicalTrials.gov/show/NCT01571388
7598875988The Effect of Different Emergency Medical Systems on the Prognosis of Traumatic Brain Injury - a Prospective StudyActive, not recruitingNo Results AvailableTraumatic Brain Injuryhttps://ClinicalTrials.gov/show/NCT01571375
7598975989A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back PainCompletedNo Results AvailableChronic Pain|Low Back Pain|AnalgesiaDrug: ALO-02|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01571362
7599075990Hemostasis in Patients With Idiopathic Thrombocytopenic PurpuraCompletedNo Results AvailableIdiopathic Thrombocytopenic Purpurahttps://ClinicalTrials.gov/show/NCT01571349

* Görseller ve İçerik tekif hakkına sahip olabilir